1. Ford AC, Yuan Y, Moayyedi P. 2020; Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and metaanalysis. Gut. 69:2113–2121. DOI:
10.1136/gutjnl-2020-320839. PMID:
32205420.
Article
2. Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. 2014; Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and metaanalysis of randomised controlled trials. BMJ. 348:g3174. DOI:
10.1136/bmj.g3174. PMID:
24846275. PMCID:
PMC4027797.
Article
3. Wong BC, Lam SK, Wong WM, et al. 2004; Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 291:187–194. DOI:
10.1001/jama.291.2.187. PMID:
14722144.
4. Li WQ, Zhang JY, Ma JL, et al. 2019; Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. BMJ. 366:l5016. DOI:
10.1136/bmj.l5016. PMID:
31511230. PMCID:
PMC6737461.
5. Kang SJ, Shin CM, Kang SJ. 2020; Effect of Helicobacter pylori eradication on the prevention of gastric cancer in the general population with or without precancerous lesions: a meta-analysis. J Dig Cancer Rep. 8:81–90.